CASPOFUNGIN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Caspofungin, and what generic alternatives are available?
Caspofungin is a drug marketed by Areva Pharms, Cipla, Fresenius Kabi Usa, Gland, Hangzhou Zhongmei, Hengrui Pharma, Pharmobedient, and Xellia Pharms Aps. and is included in eight NDAs. There is one patent protecting this drug.
The generic ingredient in CASPOFUNGIN is caspofungin acetate. There are eight drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the caspofungin acetate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Caspofungin
A generic version of CASPOFUNGIN was approved as caspofungin acetate by FRESENIUS KABI USA on December 30th, 2016.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for CASPOFUNGIN?
- What are the global sales for CASPOFUNGIN?
- What is Average Wholesale Price for CASPOFUNGIN?
Summary for CASPOFUNGIN
| US Patents: | 0 |
| Applicants: | 8 |
| NDAs: | 8 |
| Drug Prices: | Drug price information for CASPOFUNGIN |
| DailyMed Link: | CASPOFUNGIN at DailyMed |
US Patents and Regulatory Information for CASPOFUNGIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Areva Pharms | CASPOFUNGIN ACETATE | caspofungin acetate | POWDER;INTRAVENOUS | 211263-001 | Oct 1, 2021 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Gland | CASPOFUNGIN ACETATE | caspofungin acetate | POWDER;INTRAVENOUS | 207092-001 | Sep 29, 2017 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Cipla | CASPOFUNGIN ACETATE | caspofungin acetate | POWDER;INTRAVENOUS | 209489-002 | Jul 12, 2018 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Hengrui Pharma | CASPOFUNGIN ACETATE | caspofungin acetate | POWDER;INTRAVENOUS | 200833-002 | Jun 28, 2018 | AP | RX | No | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Gland | CASPOFUNGIN ACETATE | caspofungin acetate | POWDER;INTRAVENOUS | 207092-002 | Sep 29, 2017 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Xellia Pharms Aps | CASPOFUNGIN ACETATE | caspofungin acetate | POWDER;INTRAVENOUS | 205923-002 | Jul 2, 2018 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
